在当代SCLC队列中对曼彻斯特分数的外部评估

Charlie Cunniffe1, Matthew Sperrin2, Gerard Walls3

  • 1Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom.

概括

曼彻斯特得分有效地分层了现代队列中小细胞肺癌 (SCLC) 患者死亡风险. 更新的模型改善了生存概率预测,验证了其持续的临床实用性.